tradingkey.logo

Cosmos Health Inc

COSM

0.876USD

+0.016+1.90%
Horarios del mercado ETCotizaciones retrasadas 15 min
23.82MCap. mercado
PérdidaP/E TTM

Cosmos Health Inc

0.876

+0.016+1.90%
Más Datos de Cosmos Health Inc Compañía
Cosmos Health Inc. is a global healthcare company. The Company owns a portfolio of pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe and C-Sept. Through its subsidiary, Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It distributes a line of pharmaceuticals and Para pharmaceuticals, including branded generics and over the counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It is also engaged in the research and development (R&D) of patented nutraceuticals and specialized root extracts as well as in the R&D of complex generics and OTC products. It offers Cloudscreen, a multimodal platform specialized in drug repurposing, a process of uncovering new target proteins. It is also specialized in the storage and distribution of pharmaceutical and Para pharmaceutical goods.
Información de la empresa
Símbolo de cotizaciónCOSM
Nombre de la empresaCosmos Health Inc
Fecha de salida a bolsaMay 19, 2010
Director ejecutivoMr. Grigorios Siokas
Número de empleados149
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 19
Dirección- -
Ciudad- -
Bolsa de valoresNASDAQ Capital Market Consolidated
País- -
Código postal- -
Teléfono- -
Sitio Web- -
Símbolo de cotizaciónCOSM
Fecha de salida a bolsaMay 19, 2010
Director ejecutivoMr. Grigorios Siokas
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Grigorios Siokas
Mr. Grigorios Siokas
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
6.16M
--
Mr. Georgios (George) Terzis
Mr. Georgios (George) Terzis
Chief Financial Officer
Chief Financial Officer
727.26K
--
Dr. Anastasios (Tasos) Aslidis
Dr. Anastasios (Tasos) Aslidis
Independent Director
Independent Director
40.00K
--
Mr. Suhel Bhutawala
Mr. Suhel Bhutawala
Independent Director
Independent Director
30.00K
--
Mr. Demetrios G. Demetriades
Mr. Demetrios G. Demetriades
Independent Director
Independent Director
20.00K
--
Dr. Manfred Ziegler
Dr. Manfred Ziegler
Independent Director
Independent Director
20.00K
--
Mr. John James Hoidas
Mr. John James Hoidas
Independent Director
Independent Director
15.00K
--
Mr. Nikos Bardakis
Mr. Nikos Bardakis
Chief Operating Officer
Chief Operating Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Grigorios Siokas
Mr. Grigorios Siokas
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
6.16M
--
Mr. Georgios (George) Terzis
Mr. Georgios (George) Terzis
Chief Financial Officer
Chief Financial Officer
727.26K
--
Dr. Anastasios (Tasos) Aslidis
Dr. Anastasios (Tasos) Aslidis
Independent Director
Independent Director
40.00K
--
Mr. Suhel Bhutawala
Mr. Suhel Bhutawala
Independent Director
Independent Director
30.00K
--
Mr. Demetrios G. Demetriades
Mr. Demetrios G. Demetriades
Independent Director
Independent Director
20.00K
--
Dr. Manfred Ziegler
Dr. Manfred Ziegler
Independent Director
Independent Director
20.00K
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
Greece
13.32M
97.16%
UK
285.86K
2.08%
Cyprus
52.56K
0.38%
Albania
36.33K
0.26%
Bulgaria
12.18K
0.09%
Croatia (Country)
3.09K
0.02%
Por negocio
Por región
Sin datos
Estadísticas de accionistas
Actualizado: vie., 25 de jul
Actualizado: vie., 25 de jul
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Siokas (Grigorios)
21.42%
Armistice Capital LLC
6.67%
Bovopoulos (Andreas D)
6.54%
Terzis (Georgios)
2.53%
BlackRock Institutional Trust Company, N.A.
0.93%
Other
61.91%
Accionistas
Accionistas
Proporción
Siokas (Grigorios)
21.42%
Armistice Capital LLC
6.67%
Bovopoulos (Andreas D)
6.54%
Terzis (Georgios)
2.53%
BlackRock Institutional Trust Company, N.A.
0.93%
Other
61.91%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
31.08%
Hedge Fund
6.68%
Investment Advisor
1.77%
Investment Advisor/Hedge Fund
0.83%
Research Firm
0.02%
Other
59.60%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
47
11.61M
40.40%
+2.69M
2025Q1
46
9.62M
37.58%
+3.08M
2024Q4
46
5.58M
24.01%
-722.90K
2024Q3
47
6.02M
25.89%
+3.46M
2024Q2
49
2.80M
72.05%
-1.10M
2024Q1
49
2.81M
72.29%
-1.10M
2023Q4
49
4.12M
85.37%
+1.50M
2023Q3
46
2.84M
75.97%
+428.48K
2023Q2
43
2.78M
79.39%
+787.97K
2023Q1
33
2.36M
81.29%
+1.20M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Siokas (Grigorios)
6.16M
21.42%
-1.00
-0.00%
Jun 02, 2025
Armistice Capital LLC
1.92M
6.67%
+1.17M
+156.10%
Mar 31, 2025
Bovopoulos (Andreas D)
1.88M
6.54%
+1.88M
--
Dec 31, 2024
Terzis (Georgios)
727.26K
2.53%
--
--
Jun 02, 2025
BlackRock Institutional Trust Company, N.A.
267.80K
0.93%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
194.12K
0.68%
+685.00
+0.35%
Mar 31, 2025
The Vanguard Group, Inc.
134.83K
0.47%
--
--
Mar 31, 2025
UBS Financial Services, Inc.
61.67K
0.21%
-9.84K
-13.76%
Mar 31, 2025
Bardakis (Nikolaos)
45.00K
0.16%
--
--
Jun 02, 2025
Foundations Investment Advisors, LLC
42.50K
0.15%
+42.50K
--
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Proporción0%
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Dec 15, 2022
Merger
25<1
Dec 15, 2022
Merger
25<1
Dec 15, 2022
Merger
25<1
Dec 15, 2022
Merger
25<1
Fecha
Tipo
Relación
Dec 15, 2022
Merger
25<1
Dec 15, 2022
Merger
25<1
Dec 15, 2022
Merger
25<1
Dec 15, 2022
Merger
25<1
KeyAI